Search research articles
Contact Us
Filters
Showing results (301-310 of 373) with videos related to
Page
of 38
Sort By:
Molecules (Basel, Switzerland)
|
November 20, 2009
Application of the molecular combing technique to starch granules
Hua Li, Zhong-Dong Liu, Liu Boxiang, et al.
Thoracic Cancer
|
September 16, 2024
Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy
Lei Ji, Ge Song, Min Xiao, et al.
Oncology
|
August 28, 2010
Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma
Zhong-Zheng Zhu, Jian-Zhong Di, Wen-Ye Gu, et al.
BMC Cancer
|
January 31, 2018
Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps
Evelyn Hsieh, Qin Wang, Renzhi Zhang, et al.
Journal of Proteome Research
|
February 19, 2016
Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry
Ping Luo, Haoyong Yu, Xinjie Zhao, et al.
Clinical Breast Cancer
|
December 5, 2020
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis
Yiqun Han, Jiayu Wang, Yanxia Sun, et al.
Breast Cancer Research and Treatment
|
September 17, 2025
Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscape
Lei Ji, Xi Chen, Hongwei Lyu, et al.
American Journal of Cancer Research
|
September 13, 2024
Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapy
Xi Chen, Lei Ji, Xiaoyan Qian, et al.
Breast Cancer Research and Treatment
|
May 13, 2020
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer
Feng Du, Wenmiao Wang, Yongsheng Wang, et al.
Clinical Breast Cancer
|
January 12, 2019
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China
Bo Lan, Fei Ma, Mei Han, et al.
Page
of 38
Search research articles
Search
Showing results (301-310 of 373) with videos related to
Sort By:
Page
of 38
Molecules (Basel, Switzerland)
|
November 20, 2009
Application of the molecular combing technique to starch granules
Hua Li, Zhong-Dong Liu, Liu Boxiang, et al.
Thoracic Cancer
|
September 16, 2024
Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy
Lei Ji, Ge Song, Min Xiao, et al.
Oncology
|
August 28, 2010
Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma
Zhong-Zheng Zhu, Jian-Zhong Di, Wen-Ye Gu, et al.
BMC Cancer
|
January 31, 2018
Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps
Evelyn Hsieh, Qin Wang, Renzhi Zhang, et al.
Journal of Proteome Research
|
February 19, 2016
Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry
Ping Luo, Haoyong Yu, Xinjie Zhao, et al.
Clinical Breast Cancer
|
December 5, 2020
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis
Yiqun Han, Jiayu Wang, Yanxia Sun, et al.
Breast Cancer Research and Treatment
|
September 17, 2025
Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscape
Lei Ji, Xi Chen, Hongwei Lyu, et al.
American Journal of Cancer Research
|
September 13, 2024
Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapy
Xi Chen, Lei Ji, Xiaoyan Qian, et al.
Breast Cancer Research and Treatment
|
May 13, 2020
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer
Feng Du, Wenmiao Wang, Yongsheng Wang, et al.
Clinical Breast Cancer
|
January 12, 2019
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China
Bo Lan, Fei Ma, Mei Han, et al.
Page
of 38